Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals Stock Forecast

Stock Price Forecast

The 18 analysts that cover Ionis Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $57.59, which forecasts a 53.94% increase in the stock price over the next year. The lowest target is $37 and the highest is $77.

Price Target: $57.59 (+53.94%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$37	$57.59	$59	$77
Change	-1.10%	+53.94%	+57.71%	+105.83%

Analyst Ratings

The average analyst rating for Ionis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	5	6	6	7	7	7
Buy	7	7	6	4	4	4
Hold	5	5	6	6	6	6
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	18	19	19	18	18	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jessica Fye JP Morgan	JP Morgan	Hold Maintains $45 → $48	Hold	Maintains	$45 → $48	+28.31%	Jun 12, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $50	Strong Buy	Reiterates	$50	+33.65%	May 20, 2025
Debjit Chattopadhyay Guggenheim	Guggenheim	Strong Buy Maintains $65 → $64	Strong Buy	Maintains	$65 → $64	+71.08%	May 1, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $45 → $50	Strong Buy	Maintains	$45 → $50	+33.65%	May 1, 2025
Joseph Stringer Needham	Needham	Strong Buy Maintains $60 → $55	Strong Buy	Maintains	$60 → $55	+47.02%	Apr 30, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

761.43M

Increased by 7.98%

from 705.14M

Revenue Next Year

883.95M

Increased by 16.09%

from 761.43M

EPS This Year

-3.16

from -3.04

EPS Next Year

-3.23

from -3.16

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	729.26M	810.46M	587.37M	787.65M	705.14M	761.43M	883.95M	1.20B
Revenue Growth	-35.04%	11.13%	-27.53%	34.10%	-10.48%	7.98%	16.09%	35.64%
EPS	-3.18	-0.20	-1.90	-2.56	-3.04	-3.16	-3.23	-1.67
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	29	28	21

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	841.1M	1.4B	1.6B
Avg	761.4M	884.0M	1.2B
Low	701.0M	608.6M	395.9M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	19.3%	78.5%	83.6%
Avg	8.0%	16.1%	35.6%
Low	-0.6%	-20.1%	-55.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-2.43	-1.47	-0.41
Avg	-3.16	-3.23	-1.67
Low	-3.88	-4.82	-3.37

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.